Catechins have shown inhibitory properties of pro-inflammatory cytokines, interleukins IL-1β and IL-6, and tumor necrosis factor (TNF) in patients with active periodontal disease, with benefits including inflammation regression and bone resorption [87]. Here, TNF is linked to periodontal disorder.